IGC Pharma Inc (IGC)
0.5112
-0.01
(-1.69%)
USD |
NYAM |
May 03, 16:00
0.4955
-0.02
(-3.07%)
After-Hours: 20:00
IGC Pharma Cash and Short Term Investments (Quarterly): 1.378M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.378M |
September 30, 2023 | 3.124M |
June 30, 2023 | 1.95M |
March 31, 2023 | 3.35M |
December 31, 2022 | 5.033M |
September 30, 2022 | 6.816M |
June 30, 2022 | 8.053M |
March 31, 2022 | 10.46M |
December 31, 2021 | 11.94M |
September 30, 2021 | 14.40M |
June 30, 2021 | 13.32M |
March 31, 2021 | 14.63M |
December 31, 2020 | 2.968M |
September 30, 2020 | 5.001M |
June 30, 2020 | 7.801M |
March 31, 2020 | 12.34M |
December 31, 2019 | 15.19M |
September 30, 2019 | 19.10M |
June 30, 2019 | 21.56M |
March 31, 2019 | 25.61M |
December 31, 2018 | 27.03M |
September 30, 2018 | 6.408M |
June 30, 2018 | 1.021M |
March 31, 2018 | 1.658M |
December 31, 2017 | 1.691M |
Date | Value |
---|---|
September 30, 2017 | 0.597M |
June 30, 2017 | 0.3456M |
March 31, 2017 | 2.418M |
December 31, 2016 | 0.744M |
September 30, 2016 | 0.9393M |
June 30, 2016 | 1.326M |
March 31, 2016 | 1.491M |
December 31, 2015 | 0.6076M |
September 30, 2015 | 0.6379M |
June 30, 2015 | 0.6596M |
March 31, 2015 | 0.8245M |
December 31, 2014 | 1.118M |
September 30, 2014 | 1.346M |
June 30, 2014 | 2.953M |
March 31, 2014 | 1.027M |
December 31, 2013 | 0.4406M |
September 30, 2013 | 0.7268M |
June 30, 2013 | 0.6515M |
March 31, 2013 | 1.064M |
December 31, 2012 | 2.108M |
September 30, 2012 | 0.6113M |
June 30, 2012 | 0.7194M |
March 31, 2012 | 0.5629M |
December 31, 2011 | 4.445M |
September 30, 2011 | 0.7668M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.378M
Minimum
Dec 2023
21.56M
Maximum
Jun 2019
9.390M
Average
8.053M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
CEL-SCI Corp | 3.241M |
AIM ImmunoTech Inc | 13.07M |
NovaBay Pharmaceuticals Inc | 3.13M |
Protalix BioTherapeutics Inc | 44.56M |
Palatin Technologies Inc | 9.485M |